WOMAC Meaningful Within-patient Change: Results From 3 Studies of Tanezumab in Patients With Moderate-to-severe Osteoarthritis of the Hip or Knee

Philip G. Conaghan; Robert H. Dworkin; Thomas J. Schnitzer; Francis Berenbaum; Andrew G. Bushmakin; Joseph C. Cappelleri; Lars Viktrup; Lucy Abraham

doi:10.3899/jrheum.210543

Research ArticleOsteoarthritis

Open Access

WOMAC Meaningful Within-patient Change: Results From 3 Studies of Tanezumab in Patients With Moderate-to-severe Osteoarthritis of the Hip or Knee

Philip G. Conaghan, Robert H. Dworkin, Thomas J. Schnitzer, Francis Berenbaum, Andrew G. Bushmakin, Joseph C. Cappelleri, Lars Viktrup and Lucy Abraham

The Journal of Rheumatology June 2022, 49 (6) 615-621; DOI: https://doi.org/10.3899/jrheum.210543

Philip G. Conaghan

1P.G. Conaghan, MB BS, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre, Leeds, UK;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Philip G. Conaghan

Robert H. Dworkin

2R.H. Dworkin, PhD, University of Rochester, Rochester, New York, USA;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Thomas J. Schnitzer

3T.J. Schnitzer, MD, PhD, Northwestern University, Evanston, Illinois, USA;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Thomas J. Schnitzer

Francis Berenbaum

4F. Berenbaum, MD, PhD, Sorbonne Université, Paris, France;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Francis Berenbaum

Andrew G. Bushmakin

5A.G. Bushmakin, MS, J.C. Cappelleri, PhD, Pfizer Inc, Groton, Connecticut, USA;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Joseph C. Cappelleri

5A.G. Bushmakin, MS, J.C. Cappelleri, PhD, Pfizer Inc, Groton, Connecticut, USA;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Joseph C. Cappelleri

Lars Viktrup

6L. Viktrup, MD, PhD, Eli Lilly and Co., Indianapolis, Indiana, USA;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Lars Viktrup

Lucy Abraham

7L. Abraham, MSc, CPsychol, Pfizer Ltd, Surrey, UK.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Lucy Abraham
For correspondence: Lucy.Abraham{at}pfizer.com

Article
Figures & Data
Supplemental
Info & Metrics
References
PDF

PreviousNext

Data supplements

210543DataSuppl.pdf

PreviousNext

In this issue

The Journal of Rheumatology

Vol. 49, Issue 6

1 Jun 2022

Table of Contents
Table of Contents (PDF)
Index by Author
Editorial Board (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following WOMAC Meaningful Within-patient Change: Results From 3 Studies of Tanezumab in Patients With Moderate-to-severe Osteoarthritis of the Hip or Knee

Message Subject (Your Name) has forwarded a page to you from The Journal of Rheumatology

Message Body (Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

WOMAC Meaningful Within-patient Change: Results From 3 Studies of Tanezumab in Patients With Moderate-to-severe Osteoarthritis of the Hip or Knee